Alphagan-P (soln)
| Alphagan-P (soln) | |
|---|---|
| DOSAGE | 1 gtt TID. Clinically, BID is used most commonly |
| GENERIC | brimonidine 0.1% or 0.15% |
| SIZE | 5mL, 10mL, 15mL |
| INDICATIONS | Reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. |
| MECHANISM OF ACTION | alpha-2 agonist |
| MICROBIOLOGY | Relatively selective alpha-2 adrenergic receptor agonist with a peak ocular hypotensive effect occurring at two hours post-dosing. Fluorophotometric studies in animals and humans suggest that brimonidine tartrate has a dual mechanism of action by reducing aqueous humor production and increasing uveoscleral outflow. |
| CONTRAINDICATIONS & WARNINGS | History of hypersensitivity |
| PEDIATRIC USE | Contraindicated under 2 years |
| PREGNANCY | Pregnancy Category B: Teratogenicity studies have been performed in animals |
| NOTE | The “P” stands for the preservative Purite |